Thrombasthenia
What's New
Last Posted: Mar 10, 2023
- ITGA2B and ITGB3 gene mutations associated with Glanzmann thrombasthenia.
Nurden Alan T, et al. Platelets 2017 0 (1) 98-101 - [Diagnostic analysis of glanzmann thrombasthenia caused by two novel ITGA2B gene mutations].
Sun A X, et al. Zhonghua er ke za zhi = Chinese journal of pediatrics 2017 0 (9) 708-709 - High-throughput elucidation of thrombus formation reveals sources of platelet function variability.
van Geffen Johanna P, et al. Haematologica 2018 0 (6) 1256-1267 - From thrombasthenia to next generation thrombocytopenia: Neonatal alloimmune thrombocytopenia induced by maternal Glanzmann thrombasthenia.
Barg Assaf Arie, et al. Pediatric blood & cancer 2018 0 (12) e27376 - Prevalence of the Mutations Responsible for Glanzmann Thrombasthenia in Horses in Brazil.
Leite Raíssa O, et al. Animals : an open access journal from MDPI 2019 0 (11) - Molecular yield of targeted sequencing for Glanzmann thrombasthenia patients.
Owaidah Tarek, et al. NPJ genomic medicine 2019 0 4 - Association of autosomal-recessive-type distal renal tubular acidosis and Glanzmann thrombasthenia as a consequence of runs of homozygosity.
Aso Keiko, et al. Clinical case reports 2022 0 (7) e6070 - Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel.
Ross Justyne E et al. Blood advances 2021 Jan 5(2) 414-431 - Inherited Bleeding Disorders in Iraq and Consanguineous Marriage.
Al-Rahal Nidal Karim et al. International journal of hematology-oncology and stem cell research 2018 Oct 12(4) 273-281 - Study of the Relationship between HPA-1 and HPA-5 Gene Polymorphisms and Refractory to Platelet Therapy and Recombinant Factor VII in Glanzmann Thrombasthenia Patients in Southeast of Iran.
Naderi Majid, et al. International journal of hematology-oncology and stem cell research 2018 1 (1) 43-48
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 15, 2024
- Content source: